Start for free
Start for free
FM

Fort Mason Capital

North America, California, United States, San Francisco

Description

Fort Mason Capital is a private equity firm.

Investor Profile

Fort Mason Capital has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series Unknown (100%)

Country Focus

  • United Kingdom (67%)
  • United States (33%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Oncology
  • Pharmaceutical
  • Biopharma
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Fort Mason Capital frequently co-invest with?

OrbiMed
OrbiMed
North America, New York, United States, New York
Co-Investments: 2
Iroquois Capital
Iroquois Capital
North America, Tennessee, United States, Nashville
Co-Investments: 1
HBK Capital Management
HBK Capital Management
North America, Texas, United States, Dallas
Co-Investments: 1
AW
Acqua Wellington Asset Management
North America, New York, United States, New York
Co-Investments: 1
MB
Merlin Biomed
North America, New York, United States, New York
Co-Investments: 2
Clarion Capital Partners
Clarion Capital Partners
North America, New York, United States, New York
Co-Investments: 1
Heights Capital Management
Heights Capital Management
North America, California, United States, San Francisco
Co-Investments: 2
AI
Alexandra Investment Management
North America, New York, United States, Greenport
Co-Investments: 1
Highbridge Capital Management
Highbridge Capital Management
North America, New York, United States, New York
Co-Investments: 1
Bank of America Securities
Bank of America Securities
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Fort Mason Capital?

EUSA Pharma

Hemel Hempstead, Hertford, United Kingdom

EUSA Pharma is a pharmaceutical company developing and licensing late-stage oncology, pain control, and critical care products.

BiotechnologyHealth CareMedicalOncologyPharmaceutical
Series UnknownJun 28, 2007
Amount Raised: $9,100,000
EUSA Pharma

Hemel Hempstead, Hertford, United Kingdom

EUSA Pharma is a pharmaceutical company developing and licensing late-stage oncology, pain control, and critical care products.

BiotechnologyHealth CareMedicalOncologyPharmaceutical
Series UnknownNov 7, 2006
Amount Raised: $18,600,000
Genelabs Technologies

Redwood City, California, United States

Genelabs Technologies is a biopharmaceutical company engaged in the R&D of therapeutics for the treatment of infectious diseases.

BiopharmaBiotechnologyHealth CareTherapeutics
Series UnknownJun 27, 2006
Amount Raised: $8,300,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator